Details in the Victorian coroner's findings on the death of actor and martial artist Richard Norton point to consequences for the doctor who prescribed his treatment and for how Australia regulates experimental peptides. PopTV Culture reported that the Medical Board of Australia gave Dr. Jerzy Muchnicki a caution. Coroner David Ryan also recommended that the country's drug regulator review the substances involved.
Norton, 75, died March 30, 2025, after an injection of the unapproved peptides CJC-1295 and ipamorelin caused anaphylaxis and cardiac arrest. The findings are dated Oct. 28.
According to PopTV Culture, the Medical Board of Australia cautioned Muchnicki, the doctor who prescribed the peptides. The outlet did not detail the board's reasons. Ryan, meanwhile, recommended that the Therapeutic Goods Administration (TGA) assess the peptides' potential benefits and risks, USA Today reported via AOL. He also asked the regulator to consider tighter restrictions, including limiting their use to clinical trials or other experimental settings.
PopTV Culture's account of the coroner's findings gives a sequence of dates. Norton consulted Muchnicki on March 11, 2025, after earlier peptide treatment from another practitioner. He signed an informed consent form on March 15, which named anaphylaxis as a possible risk. He was prescribed the peptides on March 19. On March 25, he told the doctor he felt better.
On March 28, Norton visited the clinic after breaking a medication container and asking for a replacement. He told a nurse he had been injecting twice the prescribed dose. The nurse advised him to stick to the prescribed amount from the following week, and Muchnicki approved the replacement supply by phone, PopTV Culture reported. That evening, Norton felt hot and flushed after another injection and collapsed, according to USA Today. His wife began CPR, and he was taken to Alfred Hospital in Melbourne.
Forensic pathologist Dr. Daniel Hussey found evidence of anaphylaxis in an autopsy on April 3, 2025, PopTV Culture reported. He judged that Norton's heart condition, hypertrophic cardiomyopathy, could have made him more vulnerable during the reaction, and that his asthma could have contributed to breathing problems. The coroner did not treat either condition as the independent cause of death.
Clinical Professor Alistair Vickery, an independent expert consulted in the investigation, found too little evidence that the combination is safe, effective or beneficial for humans, according to the same outlet.
Neither substance is approved by the TGA or listed on the Australian Register of Therapeutic Goods, PopTV Culture reported. Doctors can obtain some unapproved medicines through established legal pathways, and compounding pharmacies can prepare patient-specific medicines. Norton's preparation was made by a licensed compounding pharmacy in Queensland. A prescription or pharmacy preparation does not make a medicine TGA-approved, the outlet noted. It also said the TGA has warned of risks from unapproved peptide products, including serious allergic reactions.
The case shows that a treatment can be legally prescribed and compounded while still lacking regulatory approval and strong evidence. Norton had been told the therapy was experimental and had signed a consent form listing anaphylaxis as a risk. The coroner's recommendation puts that gap in front of the TGA, which could consider whether such peptides should be confined to trials or similar settings.
USA Today noted that the findings arrive as U.S. Health Secretary Robert F. Kennedy Jr. moves to broaden access to certain unapproved peptides. The outlet did not say the two developments are connected.
The coroner's recommendations are directed at the TGA, which would need to decide whether to carry out the review and whether to tighten restrictions. No decision by the regulator has been reported.
Earlier on Around Prague: Coroner Links Actor Richard Norton's Death to Unapproved Peptide Injection
Around Prague, based on reporting by AOL.com, PopTV Culture